Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic

PURPOSE: Patients receiving platinum-based chemotherapy are at high risk of chemotherapy-induced nausea and vomiting (CINV), a distressing side effect of treatment. This post-hoc subgroup analysis of two pivotal trials evaluated the efficacy of NEPA in preventing CINV in subsets of patients with lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Hesketh, Paul J., Palmas, Marco, Nicolas, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847067/
https://www.ncbi.nlm.nih.gov/pubmed/29080920
http://dx.doi.org/10.1007/s00520-017-3936-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847067/
https://www.ncbi.nlm.nih.gov/pubmed/29080920
http://dx.doi.org/10.1007/s00520-017-3936-9

Ejemplares similares